Please assess the completion status of the following clinical trial:

Trial Title: Effect on Bleeding When Using FloSeal Matrix™ in Subjects Undergoing Endoscopic Vein Harvest (EVH)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Sign a consent form that has been approved by the Institutional Review Board.~2. Be at least 18 years of age.~3. Scheduled to undergo coronary artery bypass grafting with EVH.~4. Be able to return to Duke University Medical Center for post-operative visit.~Exclusion Criteria:~1. Be participating concurrently in another clinical trial that involves an investigational drug or device that would interfere with this study.~2. Reported allergy to FloSeal Matrix™

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm A (Type: EXPERIMENTAL): Arm A has FloSeal Matrix applied to EVH wound bed.
- Arm B (Type: NO_INTERVENTION): Arm B does not have FloSeal Matrix applied to EVH wound bed.

Based on this trial design, predict the completion outcome and termination type (if applicable).